Botulinum toxin type-A treatment in spasticity increases the central conduction time to brain stimulation

Electroencephalogr Clin Neurophysiol Suppl. 1999:51:250-9.

Authors

F Pauri¹, L Boffa, E Cassetta, P Pasqualetti, P M Rossini

Affiliation

¹ AFaR-CRCCS Centro di Ricovero e Cura a Carattere Scientifico, Divisione di Neurologia, Ospedale Fatebenefratelli, Rome, Italy.

PMID: 10590957

No abstract available

Publication types

Clinical Trial

MeSH terms

Action Potentials / drug effects
Adult
Botulinum Toxins, Type A / therapeutic use*
Central Nervous System / drug effects*
Central Nervous System / physiopathology
Evoked Potentials, Motor / drug effects
Female
H-Reflex / drug effects
Humans
Magnetics
Male
Middle Aged
Muscle Spasticity / drug therapy*
Neural Conduction / drug effects*
Neuromuscular Agents / therapeutic use*
Physical Stimulation
Reaction Time / drug effects
Time Factors

Substances

Neuromuscular Agents
Botulinum Toxins, Type A